You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Johnson and Johnson
Merck
Express Scripts
Harvard Business School

Last Updated: October 2, 2023

Investigational Drug Information for Ubiquinol


✉ Email this page to a colleague

« Back to Dashboard


What is the development status for investigational drug Ubiquinol?

Ubiquinol is an investigational drug.

There have been 13 clinical trials for Ubiquinol. The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2017.

The most common disease conditions in clinical trials are Heart Failure, Mitochondrial Diseases, and Fatigue. The leading clinical trial sponsors are Beth Israel Deaconess Medical Center, Kaneka Medical America LLC, and Kaneka Pharma America LLC.

There are five hundred and seven US patents protecting this investigational drug and five international patents.

Recent Clinical Trials for Ubiquinol
TitleSponsorPhase
Effect of Montelukast Versus Co Enzyme in SepsisAin Shams UniversityPhase 2/Phase 3
Clinical and Biochemical Assessment of the Effect of Topical Use of Coenzyme Q10 Versus Topical Corticosteroid in Management of Symptomatic Oral Lichen Planus: Randomized Controlled Clinical TrialCairo UniversityPhase 1
Effect of Ubiquinol Supplementation on Ovulation Induction in Clomiphene Citrate ResistanceSaudi German Hospital - MadinahPhase 2/Phase 3

See all Ubiquinol clinical trials

Clinical Trial Summary for Ubiquinol

Top disease conditions for Ubiquinol
Top clinical trial sponsors for Ubiquinol

See all Ubiquinol clinical trials

US Patents for Ubiquinol

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Ubiquinol ⤷  Try a Trial Methods of expressing products in mammalian cells INTREXON CEU, INC. (Blacksburg, VA) ⤷  Try a Trial
Ubiquinol ⤷  Try a Trial Nutritional supplement compositions containing C60-fullerene-phytonutrient-triglyceride complexes for sub-cellular phytonutrient delivery NextGen Research (Greenville, SC) ⤷  Try a Trial
Ubiquinol ⤷  Try a Trial Methods of using a composition comprising leukolectin for cosmetic skin treatment AQUA BIO TECHNOLOGY ASA (Bergen, NO) ⤷  Try a Trial
Ubiquinol ⤷  Try a Trial Ammonia oxidizing bacteria for treatment of eczema AOBIOME LLC (Cambridge, MA) ⤷  Try a Trial
Ubiquinol ⤷  Try a Trial Active agent loaded uniform, rigid, spherical, nanoporous calcium phosphate particles and methods of making and using the same Laboratory Skin Care, Inc. (Redwood City, CA) ⤷  Try a Trial
Ubiquinol ⤷  Try a Trial Tailored oils Corbion Biotech, Inc. (South San Francisco, CA) ⤷  Try a Trial
Ubiquinol ⤷  Try a Trial Oxidation resistant bioprosthetic tissues and preparation thereof The Children's Hospital of Philadelphia (Philadelphia, PA) ⤷  Try a Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Ubiquinol

Drugname Country Document Number Estimated Expiration Related US Patent
Ubiquinol World Intellectual Property Organization (WIPO) WO2012027533 2030-08-25 ⤷  Try a Trial
Ubiquinol Argentina AR089859 2032-02-01 ⤷  Try a Trial
Ubiquinol Australia AU2013215296 2032-02-01 ⤷  Try a Trial
Ubiquinol Brazil BR112014018957 2032-02-01 ⤷  Try a Trial
Ubiquinol Canada CA2863059 2032-02-01 ⤷  Try a Trial
Ubiquinol Chile CL2014002038 2032-02-01 ⤷  Try a Trial
Ubiquinol China CN104394693 2032-02-01 ⤷  Try a Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Johnson and Johnson
Merck
Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.